Portable Nitric Oxide Reservoir Assembly for NO2 Conversion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nitric oxide delivery systems are large, cumbersome, and inconvenient for ambulatory or home use, and they pose risks due to the formation of toxic nitrogen dioxide when oxygen is present, which can be harmful in high concentrations.
Innovation Solution
A compact nitric oxide delivery system using a reservoir assembly with a restrictor and a delivery conduit, incorporating a nitrogen dioxide source and a reducing agent to convert nitrogen dioxide to nitric oxide, ensuring safe and controlled delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nitric oxide is stored in a bottled gaseous form diluted in nitrogen gas, then the NO can be supplied for therapeutic use, but trace amounts of oxygen in the tank can oxidize the NO to nitrogen dioxide which is highly toxic if inhaled
Solution Approach 1:
The patent uses nitrogen gas as an inert atmosphere to displace oxygen from the storage tank, preventing oxidation of nitric oxide. The NO is stored diluted in nitrogen gas which does not react with NO, thereby maintaining purity and preventing formation of toxic nitrogen dioxide.
Solution Approach 2:
Nitrogen gas acts as an intermediary substance that protects nitric oxide from oxidation. By introducing nitrogen as a protective atmosphere, the system prevents direct contact between oxygen and nitric oxide, thus eliminating the harmful oxidation reaction.
2Manufacturing precision
If a reservoir assembly with restrictor and reducing agent is used to convert nitrogen dioxide to nitric oxide, then the system delivers ultra pure nitric oxide, but the system complexity increases
Solution Approach 1:
The system is divided into separate functional components: a reservoir for storing nitrogen dioxide, a restrictor for controlling flow, and a reducing agent cartridge for converting NO2 to NO. This segmentation allows each component to perform its specific function efficiently while maintaining overall system manageability.
Solution Approach 2:
A reducing agent (such as ascorbic acid or other reducing substances) is introduced as an intermediary chemical that converts nitrogen dioxide to nitric oxide. This chemical intermediary enables the transformation of the stored NO2 into the desired NO product, ensuring ultra pure delivery.
3Reliability
If existing nitric oxide delivery systems are used, then therapeutic nitric oxide can be delivered, but the systems are large and cumbersome making them unsuitable for ambulatory or home use
Solution Approach 1:
The patent combines multiple functions into a single integrated reservoir assembly that includes the storage vessel, restrictor, and reducing agent cartridge. This merging of components into one compact unit reduces the overall system size and weight, making it portable and suitable for ambulatory use while maintaining reliable NO delivery.
Solution Approach 2:
The reducing agent cartridge is nested within or attached to the reservoir assembly, with the restrictor integrated into the reservoir structure. This nested arrangement maximizes space efficiency and minimizes the external dimensions of the device, enabling portable deployment for home and ambulatory settings.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides a safe, portable, and efficient method to deliver nitric oxide, minimizing the risk of nitrogen dioxide exposure and reducing system size and weight, making it suitable for ambulatory and home use.
Implementation Method 1
incorporating a nitrogen dioxide source and a reducing agent to convert nitrogen dioxide to nitric oxide
Data Source
AI summary
A system for delivering a therapeutic amount of nitric oxide can include a reservoir including a restrictor with a length of at least 0.5 inches and at most 2 inches covered by a metal sheath, a gas supply, and a delivery conduit. A delivery conduit can include at least one cartridge and a patient interface. The at least one cartridge can include a surface-active material and a reducing agent.


